Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anus Neoplasms × Prebiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 1 Chemotherapy-Related Cognitive Impairment 1 Breast Neoplasms 1 Body Weight 1 Anus Neoplasms 1

Interventions

Fluorouracil 22 Mitomycin 15 Radiotherapy 14 Capecitabine 12 Cisplatin 11 pembrolizumab 9 Cyclophosphamide 8 Radiation 7 fludarabine 6 Biopsy 6 Specimen Handling 5 Paclitaxel 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Cetuximab 5 dehydroftorafur 4 Vaccines 4 Papillomavirus Vaccines 4 Irinotecan 4 Drug Therapy 4 Carboplatin 4 aldesleukin 3 Watchful Waiting 3 Radiotherapy, Intensity-Modulated 3 Oxaliplatin 3 Observation 3 Light Coagulation 3 Interleukin-2 3 Fluorodeoxyglucose F18 3 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡